Form of release
Polypropylene syringe tubes in cardboard boxes:
5 g
14 g
Composition
1 g of paste contains active substances:
fenbendazole - 0.05 g;
praziquantel - 0.005 g.
Pharmacological properties
The active substance - fenbendazole (benzimidazole group) inhibits the polymerization of tubulin proteins into microtubules, reduces the activity of energy enzymes, slows down the metabolism in helminths, which disrupts the absorption of nutrients (adenosine triphosphoric acid and glucose), reduces mitochondrial reactions, leads to complete exhaustion and paralysis of parasites. Fenbendazole is practically non-toxic to animals, embryotoxic and teratogenic properties have not been establi
